---
pmcid: PMC9069318
image_filename: gr5.jpg
figure_link: /pmc/articles/PMC9069318/figure/fig5/
number: Figure 5
figure_title: ''
caption: Natural products improve the therapeutic effect of cancer vaccines as adjuvants.
  (A) Curcumin and dioscorea polysaccharides sensitize cancer vaccines by down-regulating
  NF-κB signaling pathway in tumor cells. (B) Polysaccharides enhance the efficiency
  of cancer vaccines. (C) λ-Carrageenan, rutin, and uncarinic acid C sensitive cancer
  vaccines through TLR4 pathway.
article_title: Emerging role of natural products in cancer immunotherapy.
citation: Songtao Dong, et al. Acta Pharm Sin B. 2022 Mar;12(3):1163-1185.

doi: 10.1016/j.apsb.2021.08.020
journal_title: Acta Pharmaceutica Sinica. B
journal_nlm_ta: Acta Pharm Sin B
publisher_name: Elsevier

keywords:
- Natural products
- Cancer immunotherapy
- Immunosuppressive microenvironment
- Cancer vaccines
- Immuno-check points
- Adoptive immune-cells transfer immunotherapy
- AKT, alpha-serine/threonine-specific protein kinase
- B2M, beta-2-microglobulin
- bFGF, basic fibroblast growth factor
- BMDCs, bone marrow dendritic cells
- BPS, basil polysaccharide
- BTLA, B- and T-lymphocyte attenuator
- CAFs, cancer-associated fibroblasts
- CCL22, C–C motif chemokine 22
- CIKs, cytokine-induced killer cells
- COX-2, cyclooxygenase-2
- CRC, colorectal cancer
- CTL, cytotoxic T cell
- CTLA-4, cytotoxic T lymphocyte antigen-4
- DAMPs, damage-associated molecular patterns
- DCs, dendritic cells
- FDA, US Food and Drug Administration
- HCC, hepatocellular carcinoma
- HER-2, human epidermal growth factor receptor-2
- HIF-1α, hypoxia-inducible factor-1α
- HMGB1, high-mobility group box 1
- HSPs, heat shock proteins
- ICD, Immunogenic cell death
- ICTs, immunological checkpoints
- IFN-γ, interferon γ
- IL-10, interleukin-10
- LLC, Lewis lung cancer
- Mcl-1, myeloid leukemia cell differentiation protein 1
- MDSCs, myeloid-derived suppressor cells
- MHC, major histocompatibility complex class
- MITF, melanogenesis associated transcription factor
- MMP-9, matrix metalloprotein-9
- mTOR, mechanistic target of rapamycin
- NF-κB, nuclear factor kappa-light-chain-enhancer of activated B cells
- NKTs, natural killer T cells
- NSCLC, non-small cell lung cancer
- OVA, ovalbumin
- PD-1, programmed death-1
- PD-L1, programmed death receptor ligand 1
- PGE-2, prostaglandin E2
- PI3K, phosphoinositide 3-kinase
- ROS, reactive oxygen species
- STAT3, signal transducer and activator of transcription 3
- TAMs, tumor-associated macrophages
- TAP, transporters related with antigen processing
- Teffs, effective T cells
- TGF-β, transforming growth factor-β
- Th1, T helper type 1
- TILs, tumor infiltration lymphocytes
- TLR, Toll-like receptor
- TNF-α, tumor necrosis factor α
- Tregs, regulatory T cells
- TSA, tumor specific antigens
- VEGF, vascular endothelial growth factor

---
